Status:
UNKNOWN
PET-imaging of Unruptured Intracranial Aneurysm Inflammation
Lead Sponsor:
Turku University Hospital
Collaborating Sponsors:
University of Turku
Conditions:
Intracranial Aneurysm
Cerebral Aneurysm
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The main purpose of this study is to determine if PET-imaging can be used to evaluate inflammation level of intracranial aneurysms, thus helping to evaluate the rupture risk of intracranial aneurysm.
Detailed Description
Study subjects are patients who are diagnosed with an unruptured saccular intracranial aneurysm and planned for elective surgical treatment of intracranial aneurysms. Prior the planned surgery, all st...
Eligibility Criteria
Inclusion
- Fusiform intracranial aneurysms
- Following medications: Asetylsalisylic acid or non-steroidal anti-inflammatory drugs.
- Patients who have contraindication for magnetic resonance imaging (Pace Makers, foreign ferromagnetic bodies or implants)
- Patients who are allergic to contrast agents.
- Pregnancy
- Underage persons
- Patients on somatostatin analogue medication or with known neuroendocrine tumor
Exclusion
- Patients who are diagnosed with unruptured intracranial aneurysm with MRI/MRA or DSA
- Patients who are planned to undergo surgical treatment (ligation) of the intracranial aneurysm
- Age ≥18 and \<75 years.
- Saccular intracranial aneurysm with maximum diameter ≥ 3 mm.
Key Trial Info
Start Date :
January 14 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04715503
Start Date
January 14 2021
End Date
October 1 2022
Last Update
January 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Turku University Hospital
Turku, Finland, 20521